Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADAPTIMMUNE THERAPEUTICS PLC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADAP - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ -70.96M | $ -169.76M | 0% |
| 3/31/2025 | $ -37.43M | $ -69.89M | 0% |
| 12/31/2024 | $ 11.85M | $ -70.81M | -597.64% |
| 9/30/2024 | $ 79.99M | $ -44.52M | -55.65% |
| 6/30/2024 | $ 96.27M | $ -72.5M | -75.31% |
| 3/31/2024 | $ 24.38M | $ -163.41M | -670.4% |
| 12/31/2023 | $ 39.51M | $ -113.87M | -288.19% |
| 9/30/2023 | $ 88.13M | $ -95.2M | -108.03% |
| 6/30/2023 | $ 126.65M | $ -91.02M | -71.87% |
| 3/31/2023 | $ 83.88M | $ -114.16M | -136.1% |
Key Performance Insights, Last 5 Years
- ADAPTIMMUNE THERAPEUTICS PLC's latest trailing twelve months (TTM) ROE stands at -32.65%.
- Over the past 5 years, ADAPTIMMUNE THERAPEUTICS PLC's average ROE has been -161.07%.
- The median ROE for ADAPTIMMUNE THERAPEUTICS PLC during this period was -90.66%
- ADAPTIMMUNE THERAPEUTICS PLC reached its highest ROE over the past 5 years at -32.65%.
- The lowest ROE recorded by ADAPTIMMUNE THERAPEUTICS PLC in the same timeframe -670.4%
ADAPTIMMUNE THERAPEUTICS PLC's ROE vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
ROE Benchmarks
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Net Inc. Cmn. [ $ -122.84M ] / Equity [ $ 376.21M ]
(=) ROE [ -32.65% ] ADAP - Return on Equity, Last 5 years
-670.4%
Minimum
Mar 31, 2024
-32.65%
Maximum
Sep 30, 2020
-161.07%
Average
-90.66%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.51% with a standard deviation of 22.67%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.14K |
|---|---|
| min | -66.79% |
| max | 73.25% |
| average | 1.51% |
| median | 6.45% |
| std | 22.67% |